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BACKGROUND: Hydrogen sulﬁde (H2S), generated by cystathionine γ lyase 
(CSE), is an important endogenous regulator of vascular function. The aim 
of the present study was to investigate the control and consequences of CSE 
activity in endothelial cells under physiological and proatherogenic conditions.
METHODS: Endothelial cell CSE knockout mice were generated, and lung 
endothelial cells were studied in vitro (gene expression, protein sulfhydration, 
and monocyte adhesion). Mice were crossed onto the apolipoprotein E–
deﬁcient background, and atherogenesis (partial carotid artery ligation) was 
monitored over 21 days. CSE expression, H2S bioavailability, and amino acid 
proﬁling were also performed with human material.
RESULTS: The endothelial cell–speciﬁc deletion of CSE selectively increased 
the expression of CD62E and elevated monocyte adherence in the absence of 
an inﬂammatory stimulus. Mechanistically, CD62E mRNA was more stable in 
endothelial cells from CSE-deﬁcient mice, an effect attributed to the attenuated 
sulfhydration and dimerization of the RNA-binding protein human antigen 
R. CSE expression was upregulated in mice after partial carotid artery ligation 
and in atheromas from human subjects. Despite the increase in CSE protein, 
circulating and intraplaque H2S levels were reduced, a phenomenon that could 
be attributed to the serine phosphorylation (on Ser377) and inhibition of the 
enzyme, most likely resulting from increased interleukin-1β. Consistent with the 
loss of H2S, human antigen R sulfhydration was attenuated in atherosclerosis 
and resulted in the stabilization of human antigen R–target mRNAs, for 
example, CD62E and cathepsin S, both of which are linked to endothelial cell 
activation and atherosclerosis. The deletion of CSE from endothelial cells was 
associated with the accelerated development of endothelial dysfunction and 
atherosclerosis, effects that were reversed on treatment with a polysulﬁde 
donor. Finally, in mice and humans, plasma levels of the CSE substrate 
L-cystathionine negatively correlated with vascular reactivity and H2S levels, 
indicating its potential use as a biomarker for vascular disease.
CONCLUSIONS: The constitutive S-sulfhydration of human antigen R (on 
Cys13) by CSE-derived H2S prevents its homodimerization and activity, 
which attenuates the expression of target proteins such as CD62E and 
cathepsin S. However, as a consequence of vascular inﬂammation, the 
beneﬁcial actions of CSE-derived H2S are lost owing to the phosphorylation 
and inhibition of the enzyme.
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Despite intensive therapy, the clinical manifesta-tions of atherosclerosis remain the primary cause of morbidity and mortality worldwide. Athero-
sclerotic plaque formation occurs mainly at susceptible 
sites of major arteries in which disturbed ﬂow can ac-
tivate endothelial cells, leading to altered expression of 
genes involved in inﬂammatory process and the devel-
opment of vascular disease.1,2 A number of stimuli and 
factors have been found to be important in maintain-
ing endothelial cells in a quiescent and antiatherogenic 
state, including the shear stress–stimulated generation 
of nitric oxide (NO). Apart from NO, other gasotrans-
mitters are thought to play a signiﬁcant role in vascular 
homeostasis, including carbon monoxide and hydrogen 
sulﬁde (H2S). H2S is generated mainly via the reverse 
transsulfuration pathway in reactions catalyzed by 2 
pyridoxal phosphate-dependent enzymes, cystathionine 
β synthase (CBS) and cystathionine γ lyase (CSE), and 1 
pyridoxal phosphate-independent enzyme, 3-mercap-
topyruvate sulfurtransferase.3,4 The production of H2S 
in the vasculature is attributed largely to the activity of 
CSE, which generates H2S from L-cysteine and L-cysta-
thionine and has been implicated in the modulation of 
angiogenesis and vascular tone.5 However, the mecha-
nisms regulating the expression of CSE in endothelial 
cells and the molecular targets of CSE-derived H2S re-
main to be elucidated.
Although partially contradictory phenotypes on 
blood pressure changes and hyperhomocysteinemia 
have been observed that seem to depend on the ge-
netic background of the mice studied,6,7 it seems clear 
that CSE-derived H2S can exert antiatherosclerotic ef-
fects.8–10 In mice lacking CSE, both elevated adhesion 
molecule levels and enhanced leukocyte adherence 
have been described,8 whereas the overexpression of 
CSE was found to reduce atherosclerotic plaque size 
and circulating lipid levels.11 In humans, CSE has been 
detected in atherosclerotic plaques,12,13 but little is 
known about its consequences on disease development 
or outcome. The aims of this study, therefore, were to 
determine the mechanisms by which CSE expression 
and activity are regulated in endothelial cells and to 
unravel its potential role in the initiation and develop-
ment of atherosclerosis in mice and humans. Moreover, 
because at the molecular level H2S signals through the 
persulﬁdation or sulfhydration of target cysteine resi-
dues,14,15 we set out to identify physiologically relevant 
sulfhydration targets that may be altered during, and 
contribute to, disease development.
METHODS
Detailed methods are available in the online-only Data 
Supplement. Requests by researchers to access the data, 
analytical methods, and study materials for the purposes of 
reproducing the results or replicating procedures can be made 
to the corresponding author, who manages the information.
Animals
Apolipoprotein E–deﬁcient (ApoE−/−) mice were purchased 
from Charles River Laboratories (Sulzfeld, Germany). Floxed 
CSE (CSEﬂ/ﬂ) mice were generated as described7 and crossed 
with tamoxifen-inducible Cdh5-CreERT2 mice16 in the C57/
BL6J background or with Cdh5-Cre mice in the ApoE−/− back-
ground. Mice were housed in conditions that conform to 
the Guide for the Care and Use of Laboratory Animals pub-
lished by the US National Institutes of Health (publication 
No. 85-23). Animals received the usual laboratory diet, and 
all studies were approved by the animal research ethics com-
mittees in Athens (790/13-02-2014) and Darmstadt (FU1177 
and FU1189). Littermates of both sexes were used. To induce 
robust Cre activity, animals were treated with tamoxifen (75 
mg/kg IP, Sigma‐Aldrich) for 5 days.
Human Samples
Carotid plaques were prospectively collected from 24 random 
patients who had internal carotid artery stenosis of 75% to 
90% and underwent carotid endarterectomy (Table I in the 
online-only Data Supplement). Arteriographical evaluation of 
the carotid bifurcation stenosis was performed and the degree 
of luminal stenosis was determined according to NASCET 
(North American Symptomatic Carotid Endarterectomy Trial) 
Clinical Perspective
What Is New?
• Hydrogen sulﬁde generated by cystathionine γ lyase 
constitutively sulfhydrates the RNA binding protein 
human antigen R to prevent its homodimerization 
and to attenuate its activity in the vessel wall.
• The sulfhydration of human antigen R prevents its 
binding to and stabilization of target mRNAs—for 
example, CD62E (E-selectin)—ensuring their low 
expression.
• Inﬂammation results in the phosphorylation and 
inhibition of cystathionine γ lyase, which reduces 
hydrogen sulﬁde production and thus alleviates the 
inhibition of human antigen R.
• Endothelial ablation of cystathionine γ lyase 
results in increased CD62E expression and acceler-
ated development of endothelial dysfunction and 
atherosclerosis.
• Plasma levels of the cystathionine γ lyase substrate 
L-cystathionine correlate with impaired vascular 
reactivity in humans.
What Are the Clinical Implications?
• Oral supplementation with polysulﬁde donors 
(eg, SG1002) may serve as a therapeutic approach 
to attenuate atherosclerosis development in 
humans.
• Circulating L-cystathionine levels can serve as a bio-
marker for endothelial dysfunction.
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criteria. Peak systolic velocity was monitored with a Philips 
HD11 ultrasound platform (Philips, Best, the Netherlands). 
Eight additional samples of healthy thyroid arteries were used 
as the control group. Thyroid arteries were chosen from age-
matched subjects without additional comorbidities (Table I in 
the online-only Data Supplement). Samples were collected 
postmortem and evaluated by a pathologist for the possibility 
of atherosclerotic lesions. Arteries that showed no pathologi-
cal characteristics were snap-frozen for additional analysis. 
Tissue samples were either frozen and used for biochemical 
analyses or embedded in parafﬁn for immunostaining. Plasma 
from another 70 patients with internal carotid artery steno-
sis of 75% to 90% before carotid endarterectomy and 32 
age-matched healthy donors was used for amino acid proﬁl-
ing, H2S measurements, and assay of interleukin (IL)–1β levels 
(Table II in the online-only Data Supplement). All studies fol-
lowed the Code of Ethics of the World Medical Association 
(Declaration of Helsinki). The study protocols were approved 
by the Institutional Ethics Committee (Scientiﬁc and Ethic 
Committee of Hipokrateion University Hospital, PN1539), and 
all patients gave their informed consent.
Statistics
Data are expressed as mean±SEM. Statistical evaluation was 
performed with the Student t test for unpaired data. The Mann-
Whitney test was used if the sample size was <8 or popula-
tions followed non-Gaussian distribution. One-way ANOVA 
followed by the Newman-Keuls test and 2-way ANOVA with 
a Bonferroni posttest were used when appropriate. The 
Pearson correlation coefﬁcient was used to measure asso-
ciations between continuous variables. Repeated-measures 
ANOVA with a Bonferroni posttest was used when appropri-
ate. Statistical tests are described in the ﬁgure legends for 
each experiment. Central tendency and dispersion of the data 
were examined for replicates <6. Values of P<0.05 were con-
sidered statistically signiﬁcant. MetaboAnalyst17 was used to 
construct the heat map and to perform hierarchical clustering 
based on amino acid proﬁle.
RESULTS
Link Between Fluid Shear Stress, CSE 
Expression, and CD62E Expression
Given that shear stress is a key player in endothelial cell 
homeostasis and atherosclerosis development, the ex-
pression of CSE in endothelial cells along the aorta was 
assessed, concentrating on potential changes in areas 
normally associated with high shear stress/laminar ﬂow 
versus low shear stress/disturbed ﬂow. In contrast to the 
changes described for the endothelial NO synthase,18,19 
the expression of CSE was higher in the lesser curvature 
and arterial bifurcations and lower in the descending 
aorta (Figure 1A and 1B), implying that CSE expression 
was negatively regulated by shear stress. In line with 
these observations, the application of ﬂuid shear stress 
to cultured human endothelial cells resulted in a time-
dependent decrease in CSE protein levels (Figure  1C 
and 1D), as well as H2S production (Figure 1D). Shear 
stress did not alter the expression of the other H2S-gen-
erating enzymes—that is, CBS and 3-mercaptopyruvate 
sulfurtransferase—in endothelial cells (Figure IA in the 
online-only Data Supplement).
The importance of CSE in endothelial cell homeo-
stasis was studied in inducible endothelial cell–speciﬁc 
CSE knockout (CSEiΔEC) mice. Treating CSEiΔEC mice with 
tamoxifen abrogated CSE expression in endothelial 
cells and resulted in an ≈65% reduction in H2S produc-
tion (Figure 1A and Figure IB and IC in the online-only 
Data Supplement). Although intracellular adhesion 
molecule-1 and vascular cell adhesion molecule-1 were 
barely detectable in cells from wild-type and CSEiΔEC 
mice (Figure IIA in the online-only Data Supplement 
and Figure  1E), the expression of CD62E (E-selectin) 
was elevated in CSEiΔEC endothelial cells in the absence 
of any inﬂammatory stimulus. Similar effects were ob-
served in freshly isolated aortas from wild-type and 
CSEiΔEC mice (Figure IIB in the online-only Data Supple-
ment). The increased CD62E in endothelial cells from 
CSEiΔEC mice was functional because it was expressed 
on the cell surface (Figure IIC in the online-only Data 
Supplement) and correlated with an increase in mono-
cyte adhesion to CSE-deﬁcient endothelial cells under 
basal conditions (Figure IID in the online-only Data 
Supplement). Moreover, the increase in monocyte ad-
herence was abrogated in cells treated with a CD62E-
neutralizing antibody (Figure IIE in the online-only Data 
Supplement). Rescue experiments, in which CSE was 
reintroduced into CSE-deﬁcient endothelial cells, sup-
pressed the abnormal CD62E expression and abolished 
monocyte adhesion (Figure IIF and IIG in the online-
only Data Supplement). These effects were unrelated 
to changes in NO production because the differences 
between wild-type and CSE-deﬁcient endothelial cells 
were unaffected by the addition of an NO synthase in-
hibitor (Figure IIH in the online-only Data Supplement). 
Cell stimulation with IL-1β increased intracellular ad-
hesion molecule-1, vascular cell adhesion molecule-1, 
and CD62E in cells from wild-type mice but failed 
to further increase CD62E levels in CSEiΔEC mice (Fig-
ure 1E), even though vascular cell adhesion molecule-1 
and intracellular adhesion molecule-1 expression and 
monocyte adherence increased as expected (Figure IIA 
and IIB in the online-only Data Supplement).
Sulfhydration of Human Antigen R by 
CSE-Derived H2S
The selective upregulation of CD62E in endothelial 
cells lacking CSE suggested that CD62E may be directly 
targeted by CSE-derived H2S. However, it was not pos-
sible to demonstrate the sulfhydration of CD62E in 
CSE-expressing endothelial cells, indicating that the ef-
fect was indirect. Therefore, to identify potential H2S 
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targets, CSE was immunoprecipitated from murine en-
dothelial cells and coprecipitated proteins identiﬁed by 
mass spectrometry. This procedure revealed that CSE 
interacts with a number of proteins under basal con-
ditions (Table III in the online-only Data Supplement), 
including the RNA-binding protein human antigen R 
(HuR; also known as ELAV-like protein 1; Figure IIIA in 
the online-only Data Supplement). This was relevant 
inasmuch as CD62E mRNA levels are reportedly regu-
lated by HuR,20 and CD62E mRNA was more stable in 
CSE-deﬁcient cells than in CSE-expressing cells treated 
with actinomycin D (Figure IIIB in the online-only Data 
Supplement). The association of HuR with CSE could 
be conﬁrmed by immunoprecipitating the enzyme from 
CSE-overexpressing endothelial cells (Figure 2A).
HuR is an attractive candidate for sulfhydration be-
cause it possesses 3 cysteines, one of which (Cys13) is 
predicted to be highly nucleophilic and unlikely to re-
main as a free cysteine (http://clavius.bc.edu/≈clotelab/
DiANNA; http://propka.org).21–23 A biotin-thiol label-
ing assay revealed the speciﬁc, dithiothreitol-sensitive 
sulfhydration of HuR in cells from wild-type mice but 
not in cells from CSEiΔEC mice (Figure 2B). Similar results 
were obtained with a modiﬁed in situ biotin switch–
coupled proximity ligation assay (Figure 2C). To identify 
which cysteine was targeted by H2S, a series of mutants 
was generated in which Cys13, Cys245, and Cys284 
were replaced by alanine. When introduced into CSE-
expressing HEK-293 cells, the wild-type HuR and the 
Cys245Ala and Cys284Ala mutants were sulfhydrated, 
whereas the Cys13Ala mutant was not (Figure 2D).
One possible consequence of HuR sulfhydration is an 
alteration in conformation because the dimerization of 
the 2 RNA recognition motifs within the HuR protein 
requires a disulﬁde bond on Cys13.24 In agreement with 
this, the ability of the Cys13Ala HuR mutant to form di-
mers was impaired (Figure 2E). Moreover, in endothelial 
cells from wild-type mice, HuR was detected in its mo-
nomeric (inactive) and dimeric (active) forms, but only 
as a dimer in cells from CSEiΔEC mice (Figure 2F), indicat-
ing increased HuR activity in CSE-deﬁcient cells. Indeed, 
substantially more CD62E mRNA bound to HuR immu-
Figure 1. Cystathionine γ lyase (CSE) regulation and effects in endothelial cells (ECs).  
A, En face staining showing the expression of CSE (red) and CD144 (green) in different areas of aorta: (1) lesser curvature, (2) subclavian artery, (3) carotid artery, 
(4) descending aorta, and (5) thoracic artery branch point. Samples from CSEiΔEC mice were included as a negative control. DAPI (gray), bar=5μm. B, Quantiﬁca-
tion of CSE expression, n=6 mice per group (ANOVA, Newman-Keuls). C, Time course of the changes in CSE and endothelial nitric oxide synthase (eNOS) protein 
expression in human ECs exposed to ﬂuid shear stress (12 dynes/cm2) for up to 48 hours. CSE-expressing HEK-293 cells were included as a positive control (PC). 
D, Time course of the relative (Rel.) changes in CSE and eNOS protein expression (quantiﬁcation of data in B) and H2S production in human ECs exposed to ﬂuid 
shear stress (12 dynes/cm2) for up to 48 hours. All values are relative to levels in cells maintained under static conditions; n=6 to 12 experiments with 5 to 7 differ-
ent cell batches (2-way ANOVA, Bonferroni, vs static/0 hr). E, Expression of CSE and CD62E in cultured ECs from wild-type (WT) and CSEiΔEC (iΔEC) mice treated 
with solvent or interleukin (IL)–1β (30 ng/mL) for 3 hours. The graphs summarize n=6 to 9 experiments from 6 different batches of ECs (ANOVA, Newman-Keuls). 
**P<0.01. ***P<0.001. DAPI indicates 4’,6-diamidine-2’-phenylindole dihydrochloride; H2S, hydrogen sulﬁde.
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noprecipitated from CSE-deﬁcient than CSE-expressing 
endothelial cells (Figure 2G). This relationship seemed to 
be causal because the small interfering RNA-mediated 
knockdown of HuR in CSE-deﬁcient murine endothelial 
cells decreased CD62E protein expression to basal levels 
(Figure 2H). Taken together, our data indicate that the 
sulfhydration of HuR by CSE-derived H2S reduces its abil-
ity to bind to its target mRNAs (eg, CD62E).
Consequences of Disturbed Flow and 
Vascular Inﬂammation on CSE Activity
To study the inﬂuence of CSE on the induction of athero-
sclerosis associated with disturbed ﬂow and low shear 
stress, ApoE−/− mice were subjected to partial ligation of 
the left carotid artery.25 Carotid artery ligation elicited a 
clear time-dependent (over 3 weeks) increase in CSE ex-
Figure 2. Link between cystathionine γ lyase (CSE)–derived hydrogen sulﬁde and the sulfhydration of HuR on Cys13. 
A, Coprecipitation of human antigen R (HuR) with CSE from murine endothelial cells (ECs) transduced with green ﬂuorescent protein (GFP) or CSE adenoviruses 
(ad). Results are representative of a further 4 cell batches. B, Sulfhydrated HuR (S-SH) and total HuR in endothelial cells from wild-type (WT) and CSEi∆EC mice. 
DTT was included to demonstrate speciﬁcity by quenching the signal. Comparable results were obtained in an additional 5 experiments (Student t test). C, HuR 
sulfhydration (HuR-S-SH; red) in endothelial cells from WT and CSEi∆EC (i∆EC) mice detected with a biotin switch–coupled proximity ligation assay. Blue indicates 
phalloidin; and cyan, DAPI. Nonbiotinylated WT cells were used as negative control (NC). Similar results were observed with 3 additional batches of cells; bar=10 
μm. D, Sulfhydration of HuR in HEK-293 cells expressing the WT HuR or the different cysteine mutants. Similar results were obtained in 3 additional experiments. 
E, HuR monomers (m) and dimers (d) in HEK-293 cells expressing the WT HuR or the different cysteine mutants. Blots are representative of an additional 4 to 5 
experiments. F, HuR monomers and dimers in endothelial cells from WT and CSEi∆EC mice. Representative blot from n=6 different cell batches. G, CD62E RNA im-
munoprecipitated with HuR from endothelial cells from WT and CSEiΔEC mice; n=6 experiments with 4 different cell batches (Student t test). Blots demonstrate the 
equivalent immunoprecipitation (IP) of HuR and are representative of 3 additional experiments. H, Expression of CD62E in endothelial cells from WT and CSEiΔEC 
(iΔEC) mice treated with a control small interfering RNA (siRNA) (siCTL) or siRNA directed against HuR (siHuR); n=6 experiments using 4 different cell batches (2-
way ANOVA, Bonferroni). ***P<0.001. DAPI indicates 4’,6-diamidine-2’-phenylindole dihydrochloride; DTT, dithiothreitol; Sup, supernatant after IP. 
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pression in CD31-positive cells followed by an increase 
in vascular smooth muscle cells (Figure 3A). Surprisingly, 
this was associated with a decrease rather than an in-
crease in H2S production (Figure 3B). CSE expression was 
also clearly elevated in atherosclerotic plaques from indi-
viduals who had undergone endarterectomy because of 
75% to 90% internal carotid artery stenosis (Figure 3C 
and 3D). Similar to the situation in mice, circulating (Fig-
ure 3E) and intra-arterial (Figure 3F) levels of H2S were 
reduced in human subjects with atherosclerosis.
The decrease in CSE activity was not a consequence 
of substrate deﬁciency because levels of the CSE sub-
strate L-cysteine were increased in plasma from subjects 
with atherosclerosis compared with healthy donors 
(Figure 4A and Figure IV and Table IV in the online-only 
Data Supplement). In addition, levels of L-cystathionine, 
Figure 3. Cystathionine γ lyase (CSE) expression in the vascular wall.  
A, Expression of CSE (red), CD31 (green), and α-smooth muscle actin (αSMA; blue) in a nonligated (NL) carotid artery from an apolipoprotein E–deﬁcient mouse vs 
samples collected 2 days or 1 or 3 weeks after partial carotid artery ligation. White boxes mark the area magniﬁed in the right panels. Bar=20 μm. B, Time course 
of the relative (Rel.) changes in CSE expression, blood ﬂow, and plasma H2S levels in the same samples as in A; n=4 per group (each sample representing a pool 
of 3 animals) for protein and hydrogen sulﬁde (H2S) levels and n=6 to 8 animals per group for blood ﬂow (2-way ANOVA, Bonferroni). C, Comparison of CSE and 
endothelial nitric oxide synthase (eNOS) expression in plaque-free (NP; n=5) arteries and carotid plaques (n=20) from human subjects. D, Representative staining of 
CSE (red), von Willebrand factor (vWF; green), αSMA (blue), and DAPI (gray) in aortas without atherosclerotic plaque vs carotid atherosclerotic plaques. Similar results 
were observed in 5 additional subjects per group. Bar=50 μm E, Plasma H2S levels in samples from NP individuals (n=32) or subjects with atherosclerosis (Plaque; n=70; 
Mann-Whitney). F, Arterial H2S levels in arterial tissue from NP individuals (n=5) or subjects with atherosclerosis (n=20) (Mann-Whitney). **P<0.01. ***P<0.001. 
DAPI indicates 4’,6-diamidine-2’-phenylindole dihydrochloride.
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which is selectively converted to L-cysteine by CSE, were 
also markedly increased in plasma from the atheroscle-
rosis group. Circulating levels of the CBS substrate L-
homocysteine and its product L-serine were not signiﬁ-
cantly different between the 2 groups.
Next, a link between inﬂammation and altered CSE 
activity was addressed. We focused on IL-1β because it 
was signiﬁcantly elevated in patients with atherosclero-
sis compared with healthy donors (Figure 4B) and gradu-
ally increased during the development of atherosclerosis 
in mice (Figure 4C). In in vitro studies, the stimulation of 
endothelial cells with IL-1β elicited the phosphorylation 
of CSE on serine and tyrosine but not threonine residues 
(Figure VA–VC in the online-only Data Supplement). Of 
the conserved potentially phosphorylatable amino ac-
ids, the mutation of Tyr60 (human sequence) or Tyr114 
(to Phe) partially inhibited CSE activity. The mutation of 
Ser282 (to either Ala or Asp) was without effect, where-
as the mutation of Ser377 to Asp abrogated CSE activity 
(Figure VD and VE in the online-only Data Supplement). 
Although IL-1β attenuated H2S production in HEK-293 
cells transfected with the wild-type CSE, the Ser377Ala 
CSE mutant was resistant to the cytokine (Figure 4D).
Using an antibody that speciﬁcally recognized CSE 
phosphorylated on Ser377, we could demonstrate the 
serine phosphorylation of a V5-CSE fusion protein im-
munoprecipitated from IL-1β–treated human endo-
thelial cells, which coincided with a decrease in H2S 
production (Figure VF and VG in the online-only Data 
Supplement). The phosphorylation of CSE on Ser377 
A
B
E F
C D
Figure 4. Consequences of inﬂammation on cystathionine γ lyase (CSE) activity in later stages of atherosclerosis.  
A, Circulating levels of L-cysteine, L-cystathionine, L-homocysteine, and L-serine in plasma from n=26 to 32 plaque-free (NP) donors and n=64 to 70 patients with 
atherosclerosis (Plaque; Mann-Whitney). B, Circulating levels of interleukin (IL)–1β in samples from 12 NP subjects and 30 subjects with plaques (Mann-Whitney). 
C, Circulating levels of IL-1β in samples from apolipoprotein E–deﬁcient mice 2 days or 1 or 3 weeks after partial carotid artery ligation; n=4 samples per time point 
(each sample representing a pool of 3 animals; ANOVA, Newman-Keuls). D, Hydrogen sulﬁde (H2S) production detected in HEK-293 cells expressing the wild-type 
(WT) CSE or the S377A and S377D CSE mutants and treated with either solvent (Sol) or IL-1β (30 ng/mL, 18 hours); n=6 independent experiments (ANOVA, New-
man-Keuls). E, CSE phosphorylation (pCSE) on Ser377 in nonligated (NL) or ligated carotid arteries 2 days and 1 and 3 weeks after operation. Graph summarizes 
relative (Rel) levels from 4 independent experiments, with each experiment being a pool of 3 animals (ANOVA, Newman-Keuls). F, Serine phosphorylation of CSE 
in human arteries detected by proximity ligation assay (red) with phospho-serine and CSE antibodies. Cyan indicates DAPI. Right, Bright-ﬁeld images merged with 
DAPI. Similar results were observed in 5 additional subjects per group. Bar=50 μm. ***P<0.001. DAPI indicates 4’,6-diamidine-2’-phenylindole dihydrochloride.
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was also increased in murine carotid arteries 1 and 3 
weeks after ligation (Figure 4E), as well as in human 
atherosclerotic plaques (Figure 4F and Figure VH in the 
online-only Data Supplement). IL-1β also slightly at-
tenuated the activity of CBS but did not affect that 
of 3-mercaptopyruvate sulfurtransferase (Figure VIA in 
the online-only Data Supplement). The contribution of 
CBS to endothelial cell H2S production, however, was 
small because IL-1β had only a minor effect (≈6% de-
crease) on H2S production in endothelial cells lacking 
CSE (Figure VIB in the online-only Data Supplement). 
Taken together, these data suggest that vascular in-
ﬂammation elicits the phosphorylation of CSE and its 
inactivation.
Consequences of Endothelial Cell–Speciﬁc 
Deletion of CSE on Atherogenesis
To assess the role of endothelial cell CSE on athero-
genesis in a model associated with disturbed flow, 
endothelial cell–specific CSE knockout mice (CSEΔEC 
mice) were crossed onto the ApoE−/− background and 
subjected to partial ligation of the left carotid artery. 
Twenty-one days after ligation, the lumen area was 
clearly reduced in arteries from ApoE−/− mice; how-
ever, the effects were much more pronounced in 
carotid arteries from ApoExCSEΔEC mice (Figure 5A). 
Microcomputed tomography analyses confirmed the 
extensive atherosclerotic plaque formation and a de-
crease in lumen area along the length of the carotid 
artery in animals lacking endothelial cell CSE (Fig-
ure 5B).
Using a biotin switch–coupled proximity ligation 
assay, we could demonstrate HuR sulfhydration in ca-
rotid artery endothelial cells in situ (Figure 5C and 5D). 
However, this signal rapidly decreased (within 2 days) 
after partial carotid artery ligation. With disease pro-
gression, a signiﬁcant reduction in HuR sulfhydration in 
vascular smooth muscle cells also became apparent. In 
line with the decrease in H2S levels in plasma and tissue 
from humans with atherosclerosis, the sulfhydration of 
HuR was also decreased in plaque material compared 
with healthy arteries (Figure  5E). Unfortunately, the 
CSE target studied in murine endothelial cells, CD62E, 
was not detected in the available human atheroscle-
rotic plaque material, but a second HuR-regulated pro-
tein, cathepsin S (CTSS),26 was increased in the human 
plaque versus nonplaque material (Figure VIIA in the 
online-only Data Supplement). Indeed, when HuR was 
immunoprecipitated from CSE-overexpressing endo-
thelial cells, its binding to the CTSS 3′ untranslated re-
gion was decreased (Figure VIIB in the online-only Data 
Supplement). Overexpression of the phosphomimetic 
Ser377Asp CSE mutant, however, increased the bind-
ing of HuR to CTSS mRNA (Figure VIIC in the online-
only Data Supplement).
Effect of the Polysulﬁde Donor SG1002 
on the Development of Atherosclerosis
To demonstrate the importance of H2S in the process 
of atherogenesis, rescue experiments were performed 
with sodium polysulthionate (SG1002), a slow-releas-
ing polysulﬁde donor27,28 that more closely recapitu-
lates the endogenous production of H2S than fast-
releasing sulfur salts (Figure 6A). In endothelial cells 
from CSEiΔEC mice, the compound was able to restore 
HuR sulfhydration (Figure  6B), to decrease CD62E 
protein levels (Figure  6C), and to attenuate mono-
cyte adherence (Figure 6D). In mice, the addition of 
SG1002 to the drinking water increased circulating 
H2S levels by ≈60% within 48 hours (Figure 6E), a lev-
el that remained stable over the observation period. 
Plaque formation in ApoExCSEΔEC mice 21 days after 
partial carotid artery ligation was signiﬁcantly attenu-
ated in the animals that received SG1002 (Figure 6F 
and 6G). In addition, RNA immunoprecipitation stud-
ies revealed reduced binding of HuR to CTSS mRNA 
in ligated arteries from the SG1002-treated mice (Fig-
ure 6H). There was no direct effect of SG1002 on CSE 
activity because plasma levels of its substrates were 
unaffected (Figure VIIIA and VIIIB and Table V in the 
online-only Data Supplement). The effects of SG1002 
were also independent of an increase in NO synthase 
activity because nitrite levels did not differ compared 
with the vehicle-treated animals (Figure VIIIC in the 
online-only Data Supplement). In fact, plasma levels 
of L-arginine increased and levels of L-citrulline de-
creased, which would be more indicative of NO syn-
thase inhibition.
L-Cystathionine as a Biomarker of 
Endothelial Cell Dysfunction
Given that our data highlighted the importance of CSE 
activity in maintaining vascular homeostasis, we next 
addressed the possibility that changes in plasma lev-
els of the CSE substrate L-cystathionine could be used 
as a surrogate marker of CSE activity and endotheli-
al cell function. Amino acid proﬁling of plasma from 
wild-type, CSEiΔEC, and globally CSE-deﬁcient mice re-
vealed that >80% of the circulating L-cystathionine was 
seemingly metabolized by endothelial cells (Figure 7A). 
Moreover, the attenuated acetylcholine-induced relax-
ation of aortic rings from ApoExCSEΔEC versus ApoE−/− 
mice (Figure 7B) was coincident with a clear increase in 
circulating L-cystathionine but a decrease in H2S levels 
(Figure  7C). A similar reciprocal relationship between 
L-cystathionine and H2S levels was also noted between 
wild-type and CSEiΔEC mice.
In a small human cohort, noninvasive recording 
of vascular reactivity revealed impaired endothelial 
function (ﬂow-mediated dilatation) in patients with 
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atherosclerosis (Figure 7D and Table VI in the online-
only Data Supplement). In this group, endothelial dys-
function was also linked to increased plasma L-cysta-
thionine levels (Figure  7E). In a larger collective, the 
situation was clearer, and donors without atheroscle-
rosis could be classiﬁed as a L-cystathioninelow/H2S
high 
population, whereas the subjects with atherosclero-
sis were generally classed as L-cystathioninehigh/H2S
low 
(Figure  7F). Although the reciprocal relationship be-
tween L-cystathionine, H2S, and the health condition 
(no plaque versus plaque) was not fully characterized 
and a prediction model for L-cystathionine levels in 
the diseased population was not presented, our data 
indicate that, in the pathological conditions in which 
CSE fails to generate H2S, the levels of its substrate, 
L-cystathionine, increase in the circulation.
DISCUSSION
The results of the present investigation revealed that 
CSE is the major source of endogenous H2S in native 
endothelial cells and that its expression and activity 
are tightly regulated by ﬂuid shear stress and inﬂam-
mation. The basal activity of CSE was important to 
maintain low arterial levels of CD62E and to minimize 
monocyte adhesion at sites of low or disturbed ﬂow 
via a mechanism involving the sulfhydration of the 
RNA-binding protein HuR. In inﬂammatory conditions, 
Figure 5. Characterization of atherosclerosis development in endothelial cell (EC)–speciﬁc cystathionine γ lyase (CSE) knockout mice.  
A and B, Effect of partial ligation on carotid arteries from ApoE−/− and ApoExCSEΔEC (ΔEC) mice. A, Representative cross-sections showing Oil Red O staining in 
nonligated and partially ligated murine carotid arteries. B, Carotid artery lumen evaluated by microcomputed tomography scanning (ligated arteries in blue) and 
quantiﬁcation of lumen area; n=7 to 8 animals per group. Bar=200 µm (ANOVA for repeated measurements). C, Human antigen R (HuR) sulfhydration (S-SH) and 
total HuR levels in carotid arteries from ApoE−/− mice with no ligation (NL) and 2 days or 1 or 3 weeks after partial carotid artery ligation. The results are representa-
tive of 4 additional samples (each sample representing a pool of 3 animals) per group. D, S-SH (red), CD31 (green) and DAPI (blue) in cross-sections from carotid 
arteries from ApoE−/− mice with no ligation and 2 days or 1 week after partial ligation. Cyan indicates DAPI. Bar=20 μm. Graphs summarize sulfhydration events 
per EC or smooth muscle cell (SMC); n = 6 animals per group (ANOVA, Newman-Keuls). E, Sulfhydration of HuR in nonplaque (NP) material and in atherosclerotic 
plaques (Plaque) from human subjects. Results are representative of n=4 NP and n=12 plaque samples per group. **P<0.01. ***P<0.001. ApoE indicates apolipo-
protein E; DAPI, 4’,6-diamidine-2’-phenylindole dihydrochloride; DTT, dithiothreitol; and LCA, left carotid artery. 
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however, this protective mechanism was lost because 
of the phosphorylation (on Ser377) and inactivation of 
CSE. The loss of H2S and attenuated sulfhydration of 
HuR resulted in an increase in HuR dimerization and 
activity and the stabilization of the HuR-target mRNAs 
CD62E and CTSS, both of which have previously been 
linked to endothelial cell activation and atherosclerosis 
(Figure IX in the online-only Data Supplement). All of 
the observations made in a murine model of athero-
genesis could be conﬁrmed in a human cohort, making 
a strong case for a functional link between CSE inacti-
vation and accelerated disease progression. Moreover, 
at least in mice, an H2S donor was able to decrease HuR 
binding to CTSS and decelerate atherogenesis. Finally, 
in both mice and humans, circulating L-cystathionine 
levels were inversely correlated with H2S levels and en-
dothelial function, highlighting its potential usefulness 
as a biomarker of vascular disease.
Since the initial report that CSE is expressed in endo-
thelial cells,6 it has been attributed a major role in gen-
erating endothelial cell–derived H2S.
29 It was possible 
to conﬁrm this assumption by generating mice lacking 
CSE speciﬁcally in endothelial cells, in which circulat-
ing H2S levels were attenuated by ≈65%. Moreover, 
ﬂuid shear stress was found to be a major negative 
regulator of CSE expression in situ and in vitro, so that 
the expression of the enzyme was elevated at sites of 
low or disturbed blood ﬂow, which are predilection 
sites for the development of atherosclerosis. It seems 
that the CSE expressed at these sites exerts a protec-
Figure 6. Effect of SG1002 (SG) on the phenotype of ApoExCSEΔEC mice.  
A, Hydrogen sulﬁde (H2S) release from murine endothelial cells (ECs) treated with solvent (Sol), NaHS (100 µmol/L), or SG (1 µmol/L); n=4 independent cell batches 
(2 way ANOVA, Bonferroni). B, Human antigen R (HuR) sulfhydration (S-SH) in ECs from wild-type (WT) and CSEiΔEC (iΔEC) mice treated with solvent or SG. Results 
are representative of an additional 4 cell batches. C, CD62E levels in ECs from CSEiΔEC mice treated with solvent or SG for 60 minutes. Results are representative 
of an additional 5 cell batches per group. D, Monocyte adherence to ECs from WT and CSEiΔEC mice treated with solvent or SG for 60 minutes. Adherence on 
ﬁbronectin (F) was included as a negative control and interleukin-1β (IL; 30 ng/mL, 3 hours) as a positive control; n=12 experiments from 6 different cell batches 
(ANOVA, Newman-Keuls). E, H2S levels in plasma from ApoE
−/− mice given SG (400–600 ng/d) in drinking water; n=6 animals per group (ANOVA, Newman-Keuls). 
F and G, Effect of SG on the development of atherosclerosis. Representative images of Oil Red O staining of left carotid arteries (LCAs) from ApoExCSEΔEC mice 21 
days after partial ligation. Mice were treated with vehicle (Veh) or SG starting 1 day before partial ligation (F). Carotid artery lumen evaluated by microcomputed 
tomography scanning (blue indicates ligated; red, nonligated) and quantiﬁcation of lumen area 21 days after carotid artery ligation in ApoExCSEΔEC mice treated 
with vehicle or SG; n=7 to 8 animals per group (ANOVA for repeated measurements, Dunn) (G). H, RNA immunoprecipitation showing the association of the CTSS 
(cathepsin S) 3′ untranslated region (UTR) with HuR in carotid arteries from the animals shown in F and G; n=5 per group (Student t test). *P<0.05. **P<0.01. 
***P<0.001. ApoE indicates apolipoprotein E; CSE, cystathionine γ lyase; and DTT, dithiothreitol. 
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tive function that can be attributed at least partly to 
repressing the expression of CD62E. However, be-
cause CSE-derived H2S did not directly target CD62E, 
an indirect approach was taken to identify potential 
sulfhydration targets that could in turn account for 
the effects observed. Reasoning that CSE should as-
sociate with H2S targets, coprecipitation studies iden-
tiﬁed the RNA-binding protein HuR as part of the CSE 
interactome. HuR was an attractive candidate for sulf-
hydration because it possesses 3 cysteines, 1 of which 
is predicted to be highly nucleophilic. Indeed, it was 
possible to detect the sulfhydration of HuR in wild-
type endothelial cells, which was barely detectable in 
cells lacking CSE. The ﬁnding that Cys13 was targeted 
by H2S hinted at a possible molecular mechanism be-
cause Cys13 is essential for the formation of the disul-
ﬁde bonds that stabilize the active HuR homodimer.24 
The sulfhydration of HuR in CSE-expressing endothe-
lial cells meant that HuR was detected largely as an 
inactive monomer that was unable to bind its target 
mRNA, CD62E.
To evaluate the pathophysiological relevance of 
these ﬁndings, the expression and activity of CSE were 
studied in a murine model of atherogenesis linked to 
disturbed ﬂow.25 Consistent with the in vitro observa-
tions, CSE was signiﬁcantly upregulated 1 week after 
partial carotid artery ligation. More important, in sam-
ples from patients with carotid artery stenosis (75%–
85%) that demonstrated disturbed or low ﬂow, CSE 
levels were clearly upregulated. Somewhat unexpect-
edly, however, the clear increase in arterial CSE expres-
sion contrasted with the marked reduction in circulat-
ing and tissue levels of H2S, indicating that endothelial 
dysfunction and atherosclerosis were linked to the in-
hibition of CSE activity. In agreement with this obser-
vation, partial ligation of the carotid artery in mice led 
to a time-dependent decrease in the sulfhydration of 
HuR. The latter effects could not be attributed to CSE 
inactivity resulting from substrate deﬁciency because 
the amino acid proﬁle of human plasma and plaque 
material revealed that levels of the CSE-speciﬁc sub-
strate L-cystathionine were actually elevated. Given the 
link between vascular inﬂammation and atherosclero-
sis, the consequences of inﬂammatory cytokines on 
CSE activity were assessed. IL-1β was chosen for these 
studies because its levels were increased in the mouse 
model and in the available human samples. Indeed, IL-
1β elicited the serine phosphorylation of CSE, and in 
agreement with a previous report,30 it was possible to 
demonstrate that the serine phosphorylation of CSE 
on Ser377 resulted in enzyme inactivation. Making the 
link back to atherosclerosis, the serine phosphorylation 
of CSE was detectable in carotid arteries from the mu-
rine model of atherosclerosis and in plaque material 
Figure 7. L-cystathionine as a biomarker of cystathionine γ lyase (CSE) activity and endothelial cell (EC) dysfunction in humans.  
A, L-cystathionine levels in plasma from wild-type (WT), CSEiΔEC (iΔEC), and inducible CSE knockout (iKO) mice; n=6 to 12 animals per group (ANOVA, New-
man-Keuls). B, Acetylcholine (ACh)–induced relaxation (% maximum) in aortic rings from ApoE−/− and ApoExCSEΔEC mice fed a high-fat diet for 21 days; n=8 
animals per group (2-way ANOVA, Bonferroni). C, Linear correlation of circulating L-cystathionine and hydrogen sulﬁde (H2S) levels in WT, CSE
iΔEC, ApoE−/−, and 
ApoExCSEΔEC mice, n=6 animals per group (Pearson). D, Flow-mediated dilatation (FMD) and ﬂow-mediated constriction (FMC) in healthy volunteers (n=6) and 
patients (n=6) with atherosclerotic plaques. E, Linear correlation of FMD and circulating L-cystathionine levels in healthy subjects (n=6) without atherosclerosis (NP) 
and patients (n=6) with atherosclerosis (Plaque) and carotid stenosis between 75% and 90% (Pearson). F, Linear correlation of circulating L-cystathionine and H2S 
levels in samples from human subjects without plaques (n=32) and with atherosclerosis (n=70) (Pearson). **P<0.01. ***P<0.001. ApoE indicates apolipoprotein E.
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from individuals with atherosclerosis. The inactivation 
of CSE in humans could be linked to decreased sulf-
hydration of HuR and increased expression of the HuR 
target CTSS. Of course, a number of additional, recent-
ly identiﬁed targets of H2S donors could contribute to 
the phenotype observed, including sirtuin-1,31 which is 
also stabilized by HuR.20,32 A number of additional pro-
teins are physically associated with CSE in endothelial 
cells, including collagen and 2 pacsin proteins, which 
are implicated in vesicle trafﬁcking,33,34 and it will be 
interesting to determine whether the sulfhydration of 
these proteins can also affect vascular homeostasis.
Animal models of atherosclerosis are generally 
based on plaque formation resulting from a choles-
terol-rich/Western-type diet, in combination with the 
manipulation of genes involved in cholesterol metabo-
lism. Although these mouse models have provided a 
wealth of insight into disease pathogenesis, each of 
them comes with its own limitations.35 The ApoE−/− 
model of partial carotid artery ligation studied here 
was chosen because of the initial link to disturbed ﬂow 
and the accelerated development of atherosclerotic le-
sions. Given the potential limitations of this model, we 
placed particular emphasis on comparing changes ob-
served in the animal model with samples from humans 
with and without atherosclerosis. By taking this dual 
approach, we could conﬁrm the altered sulfhydration 
of HuR, the upregulation of CSE expression in athero-
sclerotic plaques, the phosphorylation of CSE, a sub-
sequent decrease in H2S levels, and alterations in the 
amino acid proﬁle that correlated with CSE activity in 
human material.
To determine the importance of endothelial cell 
CSE in atherogenesis, studies were repeated in mice 
speciﬁcally lacking CSE in endothelial cells. Consistent 
with a key role of the endothelium in atherosclerosis 
initiation, plaque size was greater and carotid lumen 
size smaller in partially ligated carotid arteries from 
ApoExCSEΔEC mice versus ApoE−/− mice. Thus, although 
H2S has been proposed to freely diffuse across mem-
branes,3 it seems that the H2S produced in smooth 
muscle cells cannot substitute for the loss of endo-
thelial cell–derived H2S. Given the apparent important 
antiatherosclerotic role of CSE, the next step was to 
assess the consequences of exogenous H2S applica-
tion on the development of atherosclerosis. The res-
cue proved to be efﬁcient in vitro because the H2S do-
nor SG1002 largely restored the sulfhydration of HuR 
and decreased the expression of CD62E and monocyte 
adhesion in CSE-deﬁcient endothelial cells. Moreover, 
the in vivo administration of SG1002 to ApoExCSEΔEC 
mice resulted in a maintained elevation in plasma H2S 
levels and a pronounced reduction in atherosclerosis. 
Preclinical studies have demonstrated that SG1002 is 
also able to attenuate cardiac dysfunction, to protect 
against pressure overload–induced heart failure (see 
review27), and to restore plasma H2S and NO levels 
to normal in patients with congestive heart failure.36 
However, there was no indication of elevated NO pro-
duction in our studies as assessed by amino acid proﬁl-
ing and assay of circulating nitrite levels, thus suggest-
ing that the antiatherosclerotic actions of SG1002 can 
be attributed directly to H2S.
The amino acid proﬁling studies also suggested 
that high plasma levels of L-cystathionine mirrored de-
creased CSE activity. Therefore, in a ﬁnal step, we set 
out to determine whether circulating levels of L-cysta-
thionine could be used as a biomarker of endothelial 
dysfunction. By comparing plasma from the available 
wild-type, globally CSE-deﬁcient, and endothelial cell–
speciﬁc CSE knockout mice, we were able to demon-
strate that altering endothelial cell CSE activity had 
a major impact on circulating L-cystathionine levels. 
High plasma L-cystathionine levels also correlated with 
impaired endothelial function in ApoExCSEΔEC versus 
ApoE−/− mice. Similarly, circulating L-cystathionine lev-
els were negatively correlated with H2S production in 
patients with atherosclerosis compared with healthy 
subjects. Moreover, in a small cohort of subjects, it 
was possible to classify those patients with atheroscle-
rosis and attenuated ﬂow-induced vasodilatation as 
being L-cystathioninehigh/H2S
low. All of these data indi-
cate that plasma levels of L-cystathionine and/or H2S 
could be useful biomarkers of endothelial dysfunction 
in nondiagnosed, asymptomatic individuals with early 
vascular disease.
Taken together, the results of this study have high-
lighted the importance of CSE in endothelial cells for 
the prevention of atherosclerosis development, identi-
ﬁed HuR as a primary molecular target of endogenous 
H2S that can account for proatherosclerotic changes in 
the vessel wall after CSE inactivation, and provided evi-
dence that L-cystathionine is an effective biomarker of 
impaired endothelial dysfunction.
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